Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
26M
-
Shares change
-
-720K
-
Total reported value, excl. options
-
$548M
-
Value change
-
-$18.9M
-
Put/Call ratio
-
0.33
-
Number of buys
-
58
-
Number of sells
-
-63
-
Price
-
$21.10
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q3 2014
167 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2014.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26M shares
of 106M outstanding shares and own 24.58% of the company stock.
Largest 10 shareholders include COLUMBIA WANGER ASSET MANAGEMENT LLC (3.24M shares), PERCEPTIVE ADVISORS LLC (2.6M shares), VANGUARD GROUP INC (2.21M shares), BlackRock Fund Advisors (1.38M shares), State Street Corp (1.3M shares), FMR LLC (1.26M shares), BlackRock Institutional Trust Company, N.A. (1.08M shares), JENNISON ASSOCIATES LLC (1.02M shares), GILDER GAGNON HOWE & CO LLC (841K shares), and D. E. Shaw & Co., Inc. (762K shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.